The Cancer Epidemiology and Chemoprevention Research Program engages a multidisciplinary group of laboratory investigators, population scientists, and clinicians who work collaboratively to elucidate the etiology of cancer and to develop Chemoprevention strategies. Emphasis is placed on mechanistic approaches as the basis for translating work from the bench to the bedside and to the community. The Program fosters discovery of novel chemopreventive agents by identifying their critical biologic targets and ultimately testing their efficacy on markers of early biologic response and on clinical disease. The Program further promotes investigations to identify carcinogenic factors and their biological effects at the molecular, genetic, and protein levels as well as inquiries into the environmental and biologic factors that modify these effects in populations. These efforts collectively involve observational studies, clinical trials (including proofof- principle and definitive Phase III trials), biomarker development, in vitro investigations, and animal studies including the use of genetically modified mice. Recent programmatic highlights include: (1) identifying induced cyclin proteolysis as a novel chemopreventive target;(2) successful conduct of proof-of-principle trials to validate this target in the clinic;(3) completion of large-scale, placebo-controlled randomized Chemoprevention trials, with findings of a reduced risk of colorectal adenoma following low-dose aspirin supplementation;and (4) extension of population-based molecular epidemiologic studies leading to detection of an association between human papillomavirus infection and squamous cell carcinoma of the skin in the general population. By promoting collaborations among basic and clinical scientists from 7 departments, the 19-member program has created advances that no single investigator could have made. Program members conduct research projects with current annual total cost funding of $10.9 million ($7.9 million from NCI, 72%). Program members published more than 300 papers during the renewal period, of which 32% derived from intra-programmatic and 33% from inter-programmatic collaborations. Over the next five years, we will continue to support initiatives with the greatest potential for clinical and public health impact on reducing the cancer burden, and to build on our growing areas of excellence in Chemoprevention, population-based studies of cancer incidence and progression, and the effects of early life exposures. The Program aims at continuing to strengthen its scientific accomplishments by organizing and fostering formal and informal mechanisms that promote collaboration and interactive projects between epidemiologists, laboratory scientists, and clinicians.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023108-32
Application #
8014994
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-12-01
Budget End
2010-11-30
Support Year
32
Fiscal Year
2010
Total Cost
$73,936
Indirect Cost
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Courtney, Andrea L; Rapuano, Kristina M; Sargent, James D et al. (2018) Reward System Activation in Response to Alcohol Advertisements Predicts College Drinking. J Stud Alcohol Drugs 79:29-38
Geller, Berta M; Frederick, Paul D; Knezevich, Stevan R et al. (2018) Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous Lesions: Policies, Practices, and Perceptions. Dermatol Surg 44:177-185
Yeager, Mark P; Guyre, Cheryl A; Sites, Brian D et al. (2018) The Stress Hormone Cortisol Enhances Interferon-?-Mediated Proinflammatory Responses of Human Immune Cells. Anesth Analg 127:556-563
Rodriguez-Garcia, Marta; Fortier, Jared M; Barr, Fiona D et al. (2018) Isolation of Dendritic Cells from the Human Female Reproductive Tract for Phenotypical and Functional Studies. J Vis Exp :
Aschbrenner, Kelly A; Bobak, Carly; Schneider, Emily J et al. (2018) Egocentric social networks and smoking among adults with serious mental illness. Transl Behav Med 8:531-539
Tapp, Stephanie J; Martin, Brook I; Tosteson, Tor D et al. (2018) Understanding the value of minimally invasive procedures for the treatment of lumbar spinal stenosis: the case of interspinous spacer devices. Spine J 18:584-592
Kuklinski, Lawrence F; Yan, Shaofeng; Li, Zhongze et al. (2018) VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival. Cancer Immunol Immunother 67:1113-1121
Shee, Kevin; Yang, Wei; Hinds, John W et al. (2018) Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer. J Exp Med 215:895-910
Gareen, Ilana F; Black, William C; Tosteson, Tor D et al. (2018) Medical Care Costs Were Similar Across the Low-dose Computed Tomography and Chest X-Ray Arms of the National Lung Screening Trial Despite Different Rates of Significant Incidental Findings. Med Care 56:403-409
Miles, Randy; Wan, Fei; Onega, Tracy L et al. (2018) Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk. J Womens Health (Larchmt) 27:748-754

Showing the most recent 10 out of 1911 publications